Browsing: Cannabis

North America’s legal cannabis industry is still in the early stages of development, shaped by complex regulation, high taxes, and fierce competition – pressures that only the most capable management teams can navigate.  That dynamic is clear when speaking with SNDL…

Mark Viner, MD, has extensive experience in schizophrenia, clozapine, psychopharmacology, and suicide research. His expertise also extends to cannabis medicine, as a member of the Clinical…